1
|
Leendertse P, van den Berg D, Castelein S, Mulder CL. Does personality moderate the association between social involvement and personal recovery in psychosis? BMC Psychiatry 2024; 24:958. [PMID: 39731057 DOI: 10.1186/s12888-024-06372-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2024] [Accepted: 12/04/2024] [Indexed: 12/29/2024] Open
Abstract
OBJECTIVE Social factors are central in personal recovery (PR) and treatment of psychosis. However, weak associations between social involvement and PR were found. We aimed to replicate this weak association, and test whether it was explained by a moderating effect of neuroticism and extraversion. METHOD This cross-sectional study included 284 psychotic disorder patients. PR was assessed using the Recovery Quality of Life (ReQoL) questionnaire. Social involvement with a formative measure of the frequency of social interaction, and neuroticism and extraversion with the NEO Five Factor Inventory (NEO-FFI). RESULTS A small direct effect of social involvement on PR (β=-0.24, p < 0.001) was found, explaining 6% of the variance in PR. The addition of neuroticism (β=-0.60, p < 0.001) predicted 41% of variance in PR; extraversion (β = 0.34, p < 0.001) predicted 16%. We did not observe a moderating effect of neither neuroticism (β=-0.06, p = 0.232), nor extraversion (β = 0.01, p = 0.956). CONCLUSION The weak association between social involvement and PR could not be explained by the moderating effect of neuroticism or extraversion. The increase in explained variance in PR implies that neuroticism is associated with PR in a direct and clinically relevant way. This emphasizes the importance of attending to negative emotions and underlying stressors in treatment of psychosis.
Collapse
Affiliation(s)
- Pien Leendertse
- Youz, Institute for Mental Healthcare, Parnassia Psychiatric Institute, Rotterdam, The Netherlands.
- Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands.
- GGZ Westelijk Noord-Brabant, Institute for Mental Healthcare, Postbus 371, Bergen op Zoom, 4600 AJ, The Netherlands.
| | - David van den Berg
- Department of Clinical Psychology, VU University and Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
- Research and Innovation, Parnassia Psychiatric Institute, The Hague, The Netherlands
| | - Stynke Castelein
- Lentis Research, Lentis Psychiatric Institute, Groningen, The Netherlands
- Faculty of Behavioral and Social Sciences, Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands
| | - Cornelis Lambert Mulder
- Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands
- Antes, Institute for Mental Healthcare, Parnassia Psychiatric Institute, Rotterdam, The Netherlands
| |
Collapse
|
2
|
Liu X, Li Y, Gao W. Subjective well-being of college students: Developmental trajectories, predictors, and risk for depression. JOURNAL OF PSYCHOLOGY IN AFRICA 2024:1-10. [DOI: 10.1080/14330237.2024.2398871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2025]
Affiliation(s)
- Xinqiao Liu
- School of Education, Tianjin University, Tianjin, China
| | - Yan Li
- School of Education, Tianjin University, Tianjin, China
| | - Wenjuan Gao
- Institute of Higher Education, Beihang University, Beijing, China
- School of Public Administration, Beihang University, Beijing, China
- Research Center for Reform and Development of Graduate Education, Beijing, China
| |
Collapse
|
3
|
de Haan L, van Tricht M, van Dijk F, Arango C, Díaz-Caneja CM, Bobes J, García-Álvarez L, Leucht S. Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders. Psychol Med 2023; 53:5986-5991. [PMID: 36520136 PMCID: PMC10520587 DOI: 10.1017/s0033291722003142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 09/16/2022] [Accepted: 09/19/2022] [Indexed: 12/23/2022]
Abstract
BACKGROUND Subjective response (SR) to antipsychotic medication is relevant for quality of life, adherence and recovery. Here, we evaluate (1) the extent of variation in SR in patients using a single antipsychotic; (2) the association between subjective and symptomatic response; and (3) predictors of SR. METHODS Open-label, single treatment condition with amisulpride in 339 patients with a first episode of a schizophrenia spectrum disorder, at most minimally treated before inclusion. Patients were evaluated at baseline, before start with amisulpride and after four weeks of treatment with the Subjective Wellbeing under Neuroleptic scale, the Positive and Negative Syndrome Scale, and the Calgary Depression Scale for Schizophrenia. RESULTS (1) 26.8% of the patients had a substantial favorable SR, and 12.4% of the patients experienced a substantial dysphoric SR during treatment with amisulpride. (2) Modest positive associations were found between SR and 4 weeks change on symptom subscales (r = 0.268-0.390, p values < 0.001). (3) Baseline affective symptoms contributed to the prediction of subjective remission, demographic characteristics did not. Lower start dosage of amisulpride was associated with a more favorable SR (r = -0.215, p < 0.001). CONCLUSIONS We conclude that variation in individual proneness for an unfavorable SR is substantial and only modestly associated with symptomatic response. We need earlier identification of those most at risk for unfavorable SR and research into interventions to improve SR to antipsychotic medication in those at risk.
Collapse
Affiliation(s)
- Lieuwe de Haan
- Department of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands
- Arkin, Institute for Mental Health, Amsterdam, the Netherlands
| | - Mirjam van Tricht
- Department of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands
| | - Floor van Dijk
- Department of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands
| | - Celso Arango
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain
| | - Covadonga M. Díaz-Caneja
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain
| | - Julio Bobes
- Department of Psychiatry, University of Oviedo, Instituto de Investigación Biosanitaria del Principado de Asturias (ISPA), INEUROPA, CIBERSAM. Oviedo, Spain
| | - Leticia García-Álvarez
- Department of Psychiatry, University of Oviedo, Instituto de Investigación Biosanitaria del Principado de Asturias (ISPA), INEUROPA, CIBERSAM. Oviedo, Spain
| | - Stefan Leucht
- Department of Psychiatry and Psychotherapy, Technical University Munich, Munich, Germany
| |
Collapse
|
4
|
Scholte-Stalenhoef AN, Pijnenborg GHM, Hasson-Ohayon I, Boyette LL. Personality traits in psychotic illness and their clinical correlates: A systematic review. Schizophr Res 2023; 252:348-406. [PMID: 36804473 DOI: 10.1016/j.schres.2023.01.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2022] [Revised: 12/18/2022] [Accepted: 01/02/2023] [Indexed: 02/17/2023]
Abstract
This systematic review focuses on personality traits according to both the Five Factor Model and Cloninger Psychobiological Model in relation to treatment related outcome variables across all stages of clinical psychotic illness. Search of Pubmed and Psychinfo databases led to final inclusion of 65 studies, which were ranked on quality and analyzed according to the associations between personality and outcome. Main findings are that higher levels of Harm Avoidance and Neuroticism are associated with higher symptom levels, tendency towards passive coping, greater self-stigma, lower quality of life, and Harm Avoidance to higher suicidality. Higher levels of Extraversion and higher levels of Self-Directedness are associated with more preference for active coping, more intrinsic motivation and higher self-esteem. Higher Novelty Seeking is related to more substance use and aggression, in men specifically. On outcome of trauma, care consumption and duration of untreated illness no consistent associations with personality traits were found. Combined evidence from both personality models however reveals a consistent pattern of personality traits related to clinical outcome in psychotic disorder, which is discussed in a dimensional manner.
Collapse
Affiliation(s)
- Anne Neeltje Scholte-Stalenhoef
- Ziekenhuis Groep Twente, Department of Psychiatry, Almelo, the Netherlands; University of Groningen, Department of Psychology, Groningen, the Netherlands.
| | | | | | - Lindy-Lou Boyette
- University of Amsterdam, Department of Clinical Psychology, Amsterdam, the Netherlands
| |
Collapse
|
5
|
Saiz-Masvidal C, Contreras F, Soriano-Mas C, Mezquida G, Díaz-Caneja CM, Vieta E, Amoretti S, Lobo A, González-Pinto A, Janssen J, Sagué-Vilavella M, Castro-Fornieles J, Bergé D, Bioque M, Lois NG, Parellada M, Bernardo M. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis. Prog Neuropsychopharmacol Biol Psychiatry 2023; 120:110645. [PMID: 36181960 DOI: 10.1016/j.pnpbp.2022.110645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2022] [Revised: 09/07/2022] [Accepted: 09/22/2022] [Indexed: 11/30/2022]
Abstract
The relationship between structural brain alterations and prediction of clinical improvement in first-episode psychosis (FEP) has been scarcely studied. We investigated whether structural covariance, a well-established approach to identify abnormal patterns of volumetric correlation across distant brain regions, which allows incorporating network-level information to structural assessments, is associated with longitudinal clinical course. We assessed a sample of 74 individuals from a multicenter study. Magnetic resonance imaging scans were acquired at baseline, and clinical assessments at baseline and at a 2-year follow-up. Participants were split in two groups as a function of their clinical improvement after 2 years (i.e., ≥ < 40% reduction in psychotic symptom severity, (n = 29, n = 45)). We performed a seed-based approach and focused our analyses on 3 cortical and 4 subcortical regions of interest to identify alterations in cortical and cortico-subcortical networks. Improvers presented an increased correlation between the volumes of the right posterior cingulate cortex (PCC) and the left precentral gyrus, and between the left PCC and the left middle occipital gyrus. They also showed an increased correlation between right posterior hippocampus and left angular gyrus volumes. Our study provides a novel mean to identify structural correlates of clinical improvement in FEP, describing clinically-relevant anatomical differences in terms of large-scale brain networks, which is better aligned with prevailing neurobiological models of psychosis. The results involve brain regions considered to participate in the multisensory processing of bodily signals and the construction of bodily self-consciousness, which resonates with recent theoretical accounts in psychosis research.
Collapse
Affiliation(s)
- Cristina Saiz-Masvidal
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Department of Clinical Sciences, School of Medicine, University of Barcelona, Spain
| | - Fernando Contreras
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Social Psychology and Quantitative Psychology, University of Barcelona, Spain.
| | - Gisela Mezquida
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain
| | - Covadonga M Díaz-Caneja
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Eduard Vieta
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Bipolar and Depressive Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Silvia Amoretti
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Bipolar and Depressive Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, Barcelona, Spain; Group of Psychiatry, Mental Health and Addictions, Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - Antonio Lobo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain; Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain
| | - Ana González-Pinto
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Instituto de Investigación Sanitaria Bioaraba (BIOARABA), Vitoria, Spain; Department of Psychiatry, Hospital Universitario de Alava, Vitoria, Spain; Universidad del País Vasco/ Euskal Harriko Unibertsitatea (UPV/EHU), País Vasco, Spain
| | - Joost Janssen
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Maria Sagué-Vilavella
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Bipolar and Depressive Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, Barcelona, Spain
| | - Josefina Castro-Fornieles
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Child and Adolescent Psychiatry and Psychology, 2017SGR881, Institut Clínic de Neurociències, Hospital Clínic Universitari, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain
| | - Daniel Bergé
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Institute of Neuropsychiatry and Addiction of the Barcelona MAR Health Park, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain
| | - Miquel Bioque
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain
| | - Noemi G Lois
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Mara Parellada
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón and School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | - Miguel Bernardo
- Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain
| | | |
Collapse
|
6
|
Chen J, Song H, Li S, Teng Z, Su Y, Chen J, Huang J. Social support and quality of life among chronically homeless patients with schizophrenia. Front Psychiatry 2022; 13:928960. [PMID: 35966475 PMCID: PMC9363777 DOI: 10.3389/fpsyt.2022.928960] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Accepted: 07/04/2022] [Indexed: 11/13/2022] Open
Abstract
This study aimed to describe the sociodemographic characteristics, social support received, and quality of life of chronically homeless patients with schizophrenia in China. A self-prepared sociodemographic questionnaire, the Social Support Rating Scale (SSRS), European Five-dimensional Health Scale (EQ-5D), and Eysenck Personality were administrated to 3,967 chronically homeless and 3,724 non-homeless patients from the Department of Xiangtan Fifth People's Hospital, Hunan, China, between April 2011 and October 2016. Results indicated that the homeless patients were more likely to live outside the city and be ethnic minorities compared with non-homeless patients. Although the married proportion was higher among homeless patients, they had a higher rate of being divorced or widowed. Notably, the homeless patients had higher employment rates before illness, despite significantly lower education (P < 0.001). Chronically homeless patients with schizophrenia showed a lower score in the SSRS (30.29 ± 7.34 vs. 26.16 ± 10.04, p < 0.001); they had significantly lower objective support, subject support, social support, and EQ-Visual Analog Scale, Eysenck Personality Questionnaire-Psychoticism, and Eysenck Personality-Neuroticism scores (p < 0.001). Homeless patients may be worse off, and could be assisted by providing accommodation, family intervention, medical services (such as pain medication), and other comprehensive measures.
Collapse
Affiliation(s)
- Jinliang Chen
- Department of Psychiatry, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China
| | - Hongli Song
- Department of Psychiatry, Fifth Ren Min Hospital of Xiangtan, Xiangtan, China
| | - Shuchun Li
- Department of Psychiatry, Fifth Ren Min Hospital of Xiangtan, Xiangtan, China
| | - Ziwei Teng
- National Clinical Research Center for Mental Diseases and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China
| | - Yuhan Su
- National Clinical Research Center for Mental Diseases and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China
| | - Jindong Chen
- National Clinical Research Center for Mental Diseases and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China.,China National Technology Institute on Mental Disorders, Changsha, China
| | - Jing Huang
- National Clinical Research Center for Mental Diseases and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China.,China National Technology Institute on Mental Disorders, Changsha, China
| |
Collapse
|
7
|
Krzyzanowski D, Agid O, Goghari V, Remington G. Cognitive discrepancies, motivation and subjective well-being in people with schizophrenia. SCHIZOPHRENIA RESEARCH-COGNITION 2021; 26:100205. [PMID: 34258238 PMCID: PMC8259292 DOI: 10.1016/j.scog.2021.100205] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 06/23/2021] [Accepted: 06/24/2021] [Indexed: 01/07/2023]
Abstract
Research indicates that people with schizophrenia often achieve similar levels of subjective well-being (SWB) compared to healthy controls despite prominent symptomatology and significant functional difficulties. Furthermore, compared to healthy controls, young-adult people with schizophrenia differ in the relative importance they place on values, or guiding life principles, associated with educational and occupational success (openness to change), suggesting that changing motivations may contribute to SWB and the apparent motivational deficits commonly reported in this population. The current study sought to better understand these relationships in middle-aged people with schizophrenia or schizoaffective disorder (n=29) versus a relatively healthy group of community controls (n=23). Participants completed measures of SWB and values. They also completed a cognitive battery and interviews concerned with mental and physical health. Patients reported similar levels of SWB compared to controls in the context of significant cognitive, social and vocational difficulties. Moreover, living consistently with values (valued living) predicted SWB in both groups. Lastly, internalized mental illness stigma was negatively associated with openness to change in the patient group. While encouraging from an emotional resiliency perspective, SWB and valued living in people with schizophrenia may hinder motivation towards treatment goals that could otherwise improve functional outcomes in this population. Patients with schizophrenia reported similar levels of SWB compared to community controls. Living consistently with values (i.e., valued living) predicted SWB in both groups. Internalized mental illness stigma was negatively associated with openness to change values in the patient group. Changing motivations may contribute to the apparent motivational deficits commonly reported in people with schizophrenia.
Collapse
Affiliation(s)
- Daniel Krzyzanowski
- University of Toronto Scarborough, Graduate Department of Psychological Clinical Science, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.,Centre for Addiction and Mental Health, 1000 Queen St W, Toronto, ON M6J 1H1, Canada
| | - Ofer Agid
- University of Toronto Scarborough, Graduate Department of Psychological Clinical Science, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.,Department of Psychiatry, University of Toronto, 27 King's College Cir, Toronto ON M5S, Canada.,Centre for Addiction and Mental Health, 1000 Queen St W, Toronto, ON M6J 1H1, Canada
| | - Vina Goghari
- University of Toronto Scarborough, Graduate Department of Psychological Clinical Science, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.,Centre for Addiction and Mental Health, 1000 Queen St W, Toronto, ON M6J 1H1, Canada
| | - Gary Remington
- University of Toronto Scarborough, Graduate Department of Psychological Clinical Science, 1265 Military Trail, Toronto, ON M1C 1A4, Canada.,Department of Psychiatry, University of Toronto, 27 King's College Cir, Toronto ON M5S, Canada.,Centre for Addiction and Mental Health, 1000 Queen St W, Toronto, ON M6J 1H1, Canada
| |
Collapse
|
8
|
Etchecopar-Etchart D, Korchia T, Loundou A, Llorca PM, Auquier P, Lançon C, Boyer L, Fond G. Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull 2020; 47:298-308. [PMID: 33252130 PMCID: PMC8451068 DOI: 10.1093/schbul/sbaa153] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Comorbid major depressive disorder (MDD) in schizophrenia (SZ; SZ-MDD) has been identified as a major prognostic factor. However, the prevalence and associated factors of SZ-MDD have never been explored in a meta-analysis. All studies assessing the prevalence of SZ-MDD in stabilized outpatients with a standardized scale or with structured interviews were included. The Medline, Web of Science, PsycINFO, and Google Scholar databases were searched. Using random effects models, we calculated the pooled estimate of the prevalence of SZ-MDD. We used meta-regression and subgroup analyses to evaluate the potential moderators of the prevalence estimates, and we used the leave-one-out method for sensitivity analyses. Of the 5633 potentially eligible studies identified, 18 studies (n = 6140 SZ stabilized outpatients) were retrieved in the systematic review and included in the meta-analysis. The pooled estimate of the prevalence of SZ-MDD was 32.6% (95% CI: 27.9-37.6); there was high heterogeneity (I2 = 92.6%), and Egger's test did not reveal publication bias (P = .122). The following factors were found to be sources of heterogeneity: publication in or after 2015, the inclusion of patients from larger studies, the assessment tools, the inclusion of patients with substance use disorder or somatic chronic diseases, age, education level, the lifetime number of hospitalizations, and antidepressant use. Two-thirds of the extracted variables could not be explored due to an insufficient amount of published data. The prevalence of MDD is high among SZ individuals. Healthcare providers and public health officials should have an increased awareness of the burden of SZ-MDD.
Collapse
Affiliation(s)
- Damien Etchecopar-Etchart
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France
| | - Theo Korchia
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France
| | - Anderson Loundou
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France
| | | | - Pascal Auquier
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France
| | - Christophe Lançon
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France
| | - Laurent Boyer
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France
| | - Guillaume Fond
- Hôpitaux Universitaires de Marseille, Department de Psychiatrie Universitaire, EA 3279: Aix-Marseille Université, CEReSS—Health Service Research and Quality of Life Center, Marseille, France,To whom correspondence should be addressed; tel: +33668102258, e-mail:
| |
Collapse
|
9
|
Hasson-Ohayon I, Scholte-Stalenhoef AN, Schirmbeck F, de Haan L, Cahn W, Pijnenborg GHM, Boyette LL. Insight, personality, and symptoms among individuals with psychosis: Cross-sectional and longitudinal relationships. Schizophr Res 2020; 222:243-250. [PMID: 32527677 DOI: 10.1016/j.schres.2020.05.042] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2019] [Revised: 03/19/2020] [Accepted: 05/17/2020] [Indexed: 10/24/2022]
Abstract
BACKGROUND Reports on the relationship between clinical insight and psychotic symptoms have shown inconsistent results, and the association between clinical insight and personality has rarely been addressed. The aim of this study was to examine whether personality is correlated cross-sectionally with insight level, and longitudinally with change in insight, beyond symptoms. METHODS Participants were a sub-sample of the Dutch Genetic Risk and Outcome of Psychosis (GROUP) project. Two hundred and eleven participants diagnosed with non-affective psychotic disorders took part in the cross-sectional part of the study, of whom 136 took part in the three-year follow-up assessment. They were administered with self-report Birchwood insight scale and NEO-Five Factor Inventory, and clinicians assessed them according to PANSS and CDS symptoms scales. RESULTS Cross-sectional analysis showed baseline self-report insight was positively related to neuroticism and agreeableness and negatively related to extraversion. Longitudinal analysis showed change in level of self-reported insight was predicted by baseline-insight and change in symptoms of disorganization. Personality factors did not predict insight change (as measured either by self-report or by clinician assessment). DISCUSSION The cross-sectional findings showed self-report insight (as opposed to clinician-rated) is associated with personality traits, suggesting negative affect is related to higher level of insight and that having insight may be influenced by the wish to comply with views of professionals, or a tendency to cover up problems. The longitudinal findings imply that not personality but change in severity of symptoms of disorganization, and possibly other variables, predicts change in insight.
Collapse
Affiliation(s)
| | | | - Frederike Schirmbeck
- Department of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands; Arkin, Institute for Mental Health, Amsterdam, the Netherlands
| | - Lieuwe de Haan
- Department of Psychiatry, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands; Arkin, Institute for Mental Health, Amsterdam, the Netherlands
| | - Wiepke Cahn
- University Medical Center Utrecht, Department of Psychiatry, Brain Centre Rudolf Magnus, Utrecht University, Utrecht, the Netherlands
| | | | - Lindy-Lou Boyette
- Department of Clinical Psychology, University of Amsterdam, Amsterdam, the Netherlands
| | | |
Collapse
|
10
|
van Dijk FA, Schirmbeck F, Boyette LL, de Haan L. Coping styles mediate the association between negative life events and subjective well-being in patients with non-affective psychotic disorders and their siblings. Psychiatry Res 2019; 272:296-303. [PMID: 30594763 DOI: 10.1016/j.psychres.2018.12.020] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Revised: 12/03/2018] [Accepted: 12/03/2018] [Indexed: 10/27/2022]
Abstract
Coping styles are associated with levels of subjective well-being. Negative life events and reduced subjective well-being are more prevalent in patients with psychotic disorders. The aims of the current study were to test a mediation model, with coping styles as potential mediators of the relation between negative life events and subjective well-being in patients with psychotic disorders (N = 259), and aimed to repeat the potential mediation model in patients' non-affected siblings (N = 309). Data pertains to a subsample of GROUP, a Dutch naturalistic cohort study. The Subjective Well-being under Neuroleptics-20 (SWN-20) scale was used to assess well-being. Coping styles were assessed with the Utrechtse Coping Lijst (UCL). Life events were assessed using an adaptation of the Interview of the Recent Life Event Scale (IRLES). Siblings, but not patients, who experienced negative life events in the previous three year period were more likely to experience a lower well-being. For both groups passive coping styles mediated the relation between negative life events and subjective well-being. Severity of positive, negative or affective symptoms did not change this relationship. Our findings point to a better recognition of copings styles as a therapeutic target to promote well-being and recovery.
Collapse
Affiliation(s)
- Floor A van Dijk
- Department of Early Psychosis, Academic Medical Centre of the University of Amsterdam, Amsterdam, the Netherlands.
| | - Frederike Schirmbeck
- Department of Early Psychosis, Academic Medical Centre of the University of Amsterdam, Amsterdam, the Netherlands; Arkin Institute for Mental Health, Amsterdam, the Netherlands
| | - Lindy-Lou Boyette
- Department of Clinical Psychology, University of Amsterdam, Amsterdam, the Netherlands
| | - Lieuwe de Haan
- Department of Early Psychosis, Academic Medical Centre of the University of Amsterdam, Amsterdam, the Netherlands; Arkin Institute for Mental Health, Amsterdam, the Netherlands
| | | |
Collapse
|